All articles

Menopause Without Suffering: Bioidentical vs Synthetic Hormones

Menopause Without Suffering: Bioidentical vs Synthetic Hormones

in pictures and a few words

What it is and why it matters

Menopause is when periods have been absent for 12 months in a row, on average around age 51. Hormone therapy can make this time easier.

  • The ovaries release fewer and fewer female hormones; swings may begin 5–10 years before this
  • Most often — hot flashes, night sweats and poor sleep; anxiety and low mood also occur
  • Hot flashes often last for years
Fewer hormonesHot flashes, poor sleepTherapy chosen with doctor

Why hormones were feared

One large study found more breast cancer, strokes and blood clots in women on hormones. Its data were later re-examined.

  • The women were on average over 60, more than 10 years past menopause
  • They were given synthetic hormones, not ones identical to their own
  • In women aged 50–59 taking estrogen alone, death and heart attack outcomes were better than in older women

Your own vs foreign hormones

Bioidentical hormones are molecules exactly like a woman’s own hormones. Synthetic ones are different molecules.

  • Estradiol — a patch, a gel or a pellet under the skin every 3–5 months
  • Progesterone — capsules by mouth or vaginally; estriol — locally for dryness
  • Synthetics — estrogens from pregnant mares’ urine and man-made progesterone look-alikes

Through the skin is gentler

Estradiol in a patch or gel is absorbed through the skin and does not pass through the liver first.

  • Does not boost blood clotting and does not affect triglycerides — one of the blood fats
  • The risk of clots does not rise — unlike estradiol tablets

Progesterone at bedtime

Progesterone identical to your own is taken before sleep. It calms and eases anxiety.

  • The usual dose is 100–200 mg at bedtime
  • Protects the inner lining of the uterus from overgrowth while estrogen is taken

Bones and heart

Estrogen helps protect the bones and, if started early after menopause, the heart too.

  • Bones lose strength fastest in the first 5–7 years after menopause
  • On hormone therapy there were almost a quarter fewer fractures, and the hip bone became denser

Dryness and frequent cystitis

Dryness, pain during sex, burning and frequent cystitis after menopause do not go away on their own. Local products with estrogen help.

  • A cream, vaginal tablets or a ring; treatment is usually long-term
  • At low doses, hormone levels in the blood are no higher than usual after menopause
  • No need to add progesterone to them

Important. After breast cancer, safety data on local estrogen products are still scarce — they are prescribed only together with the oncologist.

Check-up before starting

Before starting, you have blood tests and your breasts and uterus are checked. This is how the doctor decides whether therapy suits you and in what form.

  • Blood tests: hormones, thyroid, sugar, blood fats
  • A mammogram within the last year and a pelvic ultrasound
  • Then check-ups at 6–12 weeks, at six months and at one year
Tests and ultrasoundDecision with the doctorCheck-ups during treatment

Who should see a doctor first

Hormones are prescribed only by a doctor. They are not given during pregnancy, with current or past breast cancer, or with tumors that grow on hormones.

  • Clots in the veins or lungs, a heart attack or stroke in the last six months
  • Vaginal bleeding without a clear cause, liver disease that impairs its function
  • Migraine with aura, gallstones, a tendency to clots, very high blood pressure — the doctor decides

Important. Starting hormones for the first time after 60 or more than 10 years after menopause is not recommended. Those already taking them may continue under supervision.

In one sentence

Hormones identical to your own — estradiol through the skin and progesterone — ease hot flashes and protect the bones. They are started early after menopause, after a check-up and with a doctor.

Frequently asked questions

Bioidentical hormones are molecules chemically identical to endogenous human hormones: 17β-estradiol, micronized progesterone (Utrogestan), and estriol. Synthetic hormones include conjugated equine estrogens (CEE, Premarin) derived from pregnant mares' urine and containing the foreign molecules equilin and equilenin, as well as medroxyprogesterone acetate (MPA, Provera) — a progestin with glucocorticoid and androgenic activity.

In the French E3N cohort study (Fournier et al., 2008), transdermal estradiol combined with micronized progesterone did not increase breast cancer risk (relative risk, RR, 1.00), whereas the combination with synthetic progestins did (RR 1.69). This is why this combination is considered the safest.

Transdermal patches and gels bypass first-pass hepatic metabolism, do not increase coagulation factors, and do not affect triglycerides. According to a meta-analysis published in Climacteric (2019), transdermal estradiol, unlike oral estradiol, does not increase the risk of venous thromboembolism.

Ideally in early menopause. In the ELITE randomized trial (643 women), estradiol started within the first 6 years of menopause slowed carotid artery wall thickening, and in the Danish DOPS trial (Schierbeck et al., BMJ, 2012), 10 years of menopausal hormone therapy (MHT) started in early menopause reduced the risk of heart failure and myocardial infarction by 52% with no increase in cancer risk. Starting MHT more than 10 years after menopause or after age 60 is not recommended because of increased cardiovascular risk; women already on MHT may continue under medical supervision.

Share
Follow on TelegramGet new articles, research updates and practical health tips
Читать на русскомЧитати українською

This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician before making health decisions. Full disclaimer

Ready to Take Action?

A consultation starts where the article ends: your history, your labs, a plan for your case.

Book consultationAsk a question